Xinhui Wang

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Soldano Ferrone · 4 shared papers, 2017–2024 · strength 0.38
   • Paper Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2024.216713↗
   • Paper A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal aden… DOI 10.1186/s12967-020-02414-9↗
   • Paper Expression status of folate receptor alpha is a predictor of survival in pancreatic ductal adenocarcinoma. DOI 10.18632/oncotarget.16841↗
2. Lei Cai · 3 shared papers, 2017–2024 · strength 0.29
   • Paper Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2024.216713↗
   • Paper Expression status of folate receptor alpha is a predictor of survival in pancreatic ductal adenocarcinoma. DOI 10.18632/oncotarget.16841↗
   • Paper A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram. DOI 10.1016/j.canlet.2017.08.028↗
3. Theodoros P. Michelakos · 3 shared papers, 2017–2024 · strength 0.29
   • Paper Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2024.216713↗
   • Paper Expression status of folate receptor alpha is a predictor of survival in pancreatic ductal adenocarcinoma. DOI 10.18632/oncotarget.16841↗
   • Paper A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram. DOI 10.1016/j.canlet.2017.08.028↗
4. Vikram Deshpande · 2 shared papers, 2017–2024 · strength 0.23
   • Paper Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2024.216713↗
   • Paper Expression status of folate receptor alpha is a predictor of survival in pancreatic ductal adenocarcinoma. DOI 10.18632/oncotarget.16841↗
5. David Tsai Ting · 1 shared paper, 2024 · strength 0.17
   • Paper Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2024.216713↗
6. Yurie Sekigami · 1 shared paper, 2024 · strength 0.17
   • Paper Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2024.216713↗
7. Cristina R. Ferrone · 1 shared paper, 2024 · strength 0.17
   • Paper Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2024.216713↗
8. Paul A. Moore · 1 shared paper, 2024 · strength 0.17
   • Paper Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2024.216713↗
9. Marco Ventin · 1 shared paper, 2024 · strength 0.17
   • Paper Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2024.216713↗
10. Giulia Cattaneo · 1 shared paper, 2024 · strength 0.17
    • Paper Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2024.216713↗
11. Nabeel M. Bardeesy · 1 shared paper, 2024 · strength 0.17
    • Paper Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2024.216713↗
12. Gong Zhang · 2 shared papers, 2017–2020 · strength 0.16
    • Paper A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal aden… DOI 10.1186/s12967-020-02414-9↗
    • Paper Expression status of folate receptor alpha is a predictor of survival in pancreatic ductal adenocarcinoma. DOI 10.18632/oncotarget.16841↗
13. Cristina Rosa Ferrone · 2 shared papers, 2017 · strength 0.12
    • Paper Expression status of folate receptor alpha is a predictor of survival in pancreatic ductal adenocarcinoma. DOI 10.18632/oncotarget.16841↗
    • Paper A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram. DOI 10.1016/j.canlet.2017.08.028↗
14. Jane J. Cheng · 1 shared paper, 2020 · strength 0.09
    • Paper A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal aden… DOI 10.1186/s12967-020-02414-9↗
15. Kim C. Honselmann · 1 shared paper, 2020 · strength 0.09
    • Paper A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal aden… DOI 10.1186/s12967-020-02414-9↗
16. Tomohiro Kurokawa · 1 shared paper, 2020 · strength 0.09
    • Paper A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal aden… DOI 10.1186/s12967-020-02414-9↗
17. Cristina R. Ferrone · 1 shared paper, 2020 · strength 0.09
    • Paper A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal aden… DOI 10.1186/s12967-020-02414-9↗
18. Zhenyang Liu · 1 shared paper, 2020 · strength 0.09
    • Paper A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal aden… DOI 10.1186/s12967-020-02414-9↗
19. Andrew Scott Liss · 1 shared paper, 2020 · strength 0.09
    • Paper A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal aden… DOI 10.1186/s12967-020-02414-9↗
20. Theodore Sunki Hong · 1 shared paper, 2017 · strength 0.05
    • Paper A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram. DOI 10.1016/j.canlet.2017.08.028↗
21. Juan Cong · 1 shared paper, 2017 · strength 0.05
    • Paper A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram. DOI 10.1016/j.canlet.2017.08.028↗
22. Nan Zhang · 1 shared paper, 2017 · strength 0.05
    • Paper A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram. DOI 10.1016/j.canlet.2017.08.028↗
23. Kenneth K. Tanabe · 1 shared paper, 2017 · strength 0.05
    • Paper A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram. DOI 10.1016/j.canlet.2017.08.028↗
24. Yangyang Wang · 1 shared paper, 2017 · strength 0.05
    • Paper A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram. DOI 10.1016/j.canlet.2017.08.028↗
25. Keith D. Lillemoe · 1 shared paper, 2017 · strength 0.05
    • Paper A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram. DOI 10.1016/j.canlet.2017.08.028↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.